Sveriges mest populära poddar
AI Brief
AI Brief

EP 604 : Anthropic’s Claude Scores Protein Design Breakthrough & Replit Launches Free Mode – AI News

15 min•21 augusti 2026

Om avsnittet

Ever wondered whether AI can actually design drugs? In this episode we dive into Anthropic’s newest triumph: Claude’s autonomous protein‑design campaigns that produced working molecules on 14 out of 15 targets, smashing typical success rates. We break down the research, the role of Mythos Preview and Opus 4.8, and why this could be the “early glimmer” Dario Amodei hinted at just days earlier.We also unpack Replit’s brand‑new Free Mode, the clever Luna‑powered setting that lets Core‑plan users run everyday chats and tasks without draining credits. Hear how the 80 % price cut on Luna is reshaping the economics of AI‑powered products and what CEO Michele Catasta and Sam Altman think about the coming entrepreneurial boom.Plus, a rapid roundup of today’s AI headlines: Stripe’s bold claim that we’ve hit the singularity, Meta’s desktop Mac app for Meta AI, OpenAI’s unprecedented pause on reinforcement‑learning training, Z AI’s GLM‑5.3 climb on the Intelligence Index, Cerebras’s CS‑4 chip delivering up to 30× GPU speed, and OpenAI’s new Private Safety Processing layer.We’ll also spotlight the hottest tools to boost your workflow—from Google’s Gemini‑focused Student Hub to the collaborative workspace Cumora, the 247Rep customer‑conversation automator, and Simplepages for instant landing‑page creation.Tune in for the insights, share with fellow AI enthusiasts, and hit subscribe so you never miss a breakthrough. Whether you’re a researcher, developer, or curious tech fan, this episode gives you the context you need to stay ahead in the fast‑moving AI landscape.Tools mentioned: Claude (Mythos Preview, Opus 4.8, Opus 5), Replit Free Mode (Luna), Twist Bioscience, Adaptyv Bio, Stripe, Meta AI desktop app, OpenAI Private Safety Processing, GLM‑5.3, Cerebras CS‑4, Student Hub, Cumora, 247Rep, Simplepages.

AI Brief med MonPod finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.